Dr. Yibin Xie 解亦斌
Chief Physician
Department of Pancreatic and Gastric Surgery, Cancer Hospital, Chinese Academy of Medical Sciences (National Cancer Center), Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Gastric cancer, gastric stromal tumors, pancreatic cancer, solid pseudopapillary tumors of the pancreas, duodenal and small intestine tumors, ampullary tumors, and biliary tract tumors. Specializes in laparoscopic minimally invasive surgery, complex reoperations, large abdominal tumors, and pancreaticoduodenectomy.
Dr. Xie holds a medical doctorate and serves as Chief Physician and master’s supervisor. A research-oriented clinical expert from Yuncheng, Shanxi, Dr. Xie focuses on the diagnosis and treatment of abdominal tumors.
Professional roles
- Member, Beijing Branch of the Chinese Medical Association
Name order: in Chinese the family name comes first (Xie Yibin). Papers usually list the name as Yibin Xie or Xie Y.
Selected publications
60 papers on PubMed matched by name and affiliation; 12 as first or senior author since 2016. Most recent first- or senior-author papers:
- Front Oncol, 2026 (senior author): A multi-task deep learning framework for simultaneous prediction of microsatellite instability and tumor mutational burden in gastric cancer from histopathological images. PubMed 42339119
- Front Oncol, 2023 (senior author): An improvement in the reconstruction of digestive tract after total gastrectomy: ultra-short cecum. PubMed 37727214
- Chin Med J (Engl), 2023 (senior author): IGFBP-3 promotes cachexia-associated lipid loss by suppressing insulin-like growth factor/insulin signaling. PubMed 37014770
- World J Surg Oncol, 2023 (senior author): Identification of critical prognosis signature associated with lymph node metastasis of stomach adenocarcinomas. PubMed 36823639
- Front Oncol, 2022 (senior author): Long-term nutritional status after total gastrectomy was comparable to proximal gastrectomy but with much less reflux esophagitis and anastomotic stenosis. PubMed 36387202
- World J Gastroenterol, 2022 (senior author): No long-term survival benefit with sustained-release 5-fluorouracil implants in patients with stages II and III gastric cancer. PubMed 36304092
- BMC Surg, 2022 (senior author): Hyperthermic intraperitoneal chemotherapy for patients with gastric cancer based on laboratory tests is safe: a single Chinese center analysis. PubMed 36115993
- Front Oncol, 2022 (senior author): Dynamic monitoring revealed a slightly prolonged waiting time for total gastrectomy during the COVID-19 pandemic without increasing the short-term complications. PubMed 36119493
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion